146.15 0.00 (0.00%)
After hours: 5:20PM EDT
| Previous Close | 139.82 |
| Open | 138.68 |
| Bid | 145.66 x 900 |
| Ask | 147.08 x 1100 |
| Day's Range | 138.20 - 146.32 |
| 52 Week Range | 79.26 - 176.90 |
| Volume | 1,938,420 |
| Avg. Volume | 1,502,800 |
| Market Cap | 21.628B |
| Beta (3Y Monthly) | 1.22 |
| PE Ratio (TTM) | 80.35 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
The event will be held on October 8, 2019 in Chicago and will feature industry experts from leading companies, including a keynote panel with Colgate-Palmolive, Unilever, and Syngenta sharing best practices to improve speed and agility across the product lifecycle.
In an interview with Capital Market Laboratories (CMLviz), Chief Financial Officer of Veeva Systems (VEEV) Tim Cabral had a clear message: For Veeva, the opportunities are as big as they've ever been. The "Vault" suite of applications has only reached about ten percent of the addressable market in life sciences, and what took Veeva to a billion dollars will fuel the next several billion.
Industry comes together to advance product development and stay ahead of changing regulations
2019 Veeva R&D Summit — An increasing number of emerging biopharma companies and leading contract research organizations (CROs) are adopting Vault CDMS from Veeva Systems (VEEV) to manage their clinical data. More life sciences organizations are using Veeva Vault CDMS for multiple clinical trials to drive greater speed and agility in study execution. Vault CDMS is a modern cloud application for clinical data management that combines EDC, coding, data cleaning, and reporting on a single cloud platform.
Veeva Systems today announced that Tim Cabral, CFO, will present at the Deutsche Bank 2019 Technology Conference on Wednesday, September 11, 2019, at 9:20 a.m. Pacific time in Las Vegas.
Veeva Systems (VEEV) today announced that OPKO Health (OPK), a diagnostic and pharmaceutical company, selected multichannel Veeva CRM to enable field teams to engage in relevant, timely, and compliant interactions with healthcare professionals (HCPs) through preferred channels. Veeva CRM gives OPKO Health the most advanced capabilities and complete customer insights. “Veeva CRM helps our field teams better understand our customers in real time so we can engage more effectively and efficiently in the right channel,” said Adria Parks-Herrera, senior marketing director at OPKO Health.
Veeva Systems (VEEV) today announced that Alvotech selected Veeva Vault QMS to streamline quality processes across the organization with improved efficiency and compliance. With Veeva Vault Quality Suite, Alvotech can reduce overhead while providing visibility into quality processes across the organization.
Veeva Systems (VEEV) today announced a new quality risk management (QRM) capability in Veeva Vault QMS. Life sciences companies can now take a proactive approach to monitoring risks and implementing mitigation plans throughout the entire product lifecycle for enhanced product quality and patient safety.
An increasing number of contract research organizations (CROs) are adopting Veeva Development Cloud applications from Veeva Systems (VEEV) in an industrywide drive to improve efficiency, compliance, and collaboration in working with sponsors and sites. More than 55 CROs, including 6 of the top 7 global CROs, are modernizing their clinical, regulatory, and quality processes to accelerate drug development. “We have significantly improved our trial efficiency by streamlining clinical operations with Veeva Vault eTMF,” said Julie Ross, president at Advanced Clinical.
More companies are unifying their global data, content, and processes across clinical operations with Veeva Vault CTMS. In less than a year, the number of Vault CTMS customers has doubled to 50, signaling the industry’s continued shift in adopting the advanced cloud application from Veeva Systems (VEEV) to improve trial performance. “CTMS is a highly complex area that has been held back for decades by a lack of innovation,” said Henry Galio, senior director for Veeva Vault CTMS.
Modern cloud technology enables device and diagnostics manufacturers to keep pace with changing regulations and growing complexity
Total Revenues of $266.9M, up 27% Year-over-year;
World’s most innovative pharmaceutical, biotech, and medical device companies gather to showcase progress in speeding product development
Veeva Systems (VEEV) today announced the MuleSoft Connector for Veeva Vault. MuleSoft, a Salesforce company, is working together with Veeva to make it faster and easier for life sciences companies to connect Veeva Vault applications with other enterprise systems.
Veeva Vault CDMS to manage clinical data for expanded access program for a neurologic disorder treatment
Veeva Systems (VEEV) today announced the appointment of Mary Lynne Hedley to the company’s Board of Directors. Dr. Hedley brings 23 years of experience leading numerous innovative life sciences companies. Dr. Hedley also currently serves on the board of directors of biopharmaceutical company, Millendo Therapeutics, Inc.
Veeva Systems (VEEV) today announced Veeva Vault Safety.AI, a new artificial intelligence (AI) application that automates case intake to reduce the time and effort of manual data entry for more efficient case processing. Together with Vault Safety and Vault SafetyDocs, Veeva offers the first integrated suite of cloud applications on a common platform to manage the end-to-end drug safety lifecycle, from case intake and adverse event processing to authoring and submissions.
Veeva Systems will announce financial results for its second quarter which ended July 31, 2019 after the market close on August 27, 2019. Veeva will host a conference call and webcast that day at 1:30 p.m.
Veeva Systems (VEEV) today announced that Celltrion, one of the top South Korean biopharmaceutical companies, implemented Veeva Vault eTMF to improve oversight across its trial master file (TMF) processes and achieve greater compliance. “Veeva Vault eTMF will help us streamline our clinical operations and give us a complete view of study documents at every stage of drug development,” said Sueun Song, head of clinical operations at Celltrion.